• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿拉伯联合酋长国迪拜依赖输血的地中海贫血患者的生产力损失及相关成本

Productivity Loss and Associated Costs Among Patients with Transfusion-Dependent Thalassemia in Dubai, United Arab Emirates.

作者信息

Alshamsi Shaikha, Hamidi Samer, Ozgen Narci Hacer

机构信息

School of Health and Environmental Studies, Hamdan Bin Mohammed Smart University, Dubai, United Arab Emirates.

School of Health and Environment Studies, Hamdan Bin Mohammed Smart University, Dubai, United Arab Emirates.

出版信息

Clinicoecon Outcomes Res. 2021 Sep 29;13:853-862. doi: 10.2147/CEOR.S334724. eCollection 2021.

DOI:10.2147/CEOR.S334724
PMID:34616164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8487795/
Abstract

OBJECTIVE

The aim of this study was to assess the indirect burden of patients with transfusion-dependent thalassemia (TDT) in Dubai, the United Arab Emirates (UAE).

METHODS

Adult patients with TDT were enrolled during blood transfusion sessions. Productivity loss for patients in the preceding four weeks was reported using the validated iMTA Productivity Cost Questionnaire (iPCQ).

RESULTS

A total of 161 adult patients with TDT were included in the study. The annual total productivity loss cost at paid work among 79 employed patients was AED 17,230 (USD 4691) (95% CI: 12,302-22,159), out of which absenteeism contributed AED 10,328 (USD 2812) and presenteeism contributed AED 6902 (USD 1879), whereas the annual total productivity loss cost at unpaid work was AED 4053 (USD 1104) (95% CI: 3471-4661). The annual mean total indirect cost for paid and unpaid work was AED 21,283 (USD 5795). Monthly income, nationality, and having two and more disease complications were the significant predictors of higher productivity loss costs. Having previously had a splenectomy was a negative and significant predictor of productivity loss costs.

CONCLUSION

TDT was associated with substantial productivity loss and indirect costs in the UAE. Health policies that aim to control transfusion-dependent thalassemia effectively are necessary and could result in cost savings for patients and employers.

摘要

目的

本研究旨在评估阿拉伯联合酋长国迪拜输血依赖型地中海贫血(TDT)患者的间接负担。

方法

成年TDT患者在输血期间入组。使用经过验证的iMTA生产力成本问卷(iPCQ)报告患者在前四周的生产力损失。

结果

本研究共纳入161例成年TDT患者。79名就业患者在有偿工作中的年度总生产力损失成本为17230阿联酋迪拉姆(4691美元)(95%CI:12302-22159),其中旷工造成10328阿联酋迪拉姆(2812美元),出勤但生产力下降造成6902阿联酋迪拉姆(1879美元),而无偿工作的年度总生产力损失成本为4053阿联酋迪拉姆(1104美元)(95%CI:3471-4661)。有偿和无偿工作的年度平均总间接成本为21283阿联酋迪拉姆(5795美元)。月收入、国籍以及患有两种及以上疾病并发症是生产力损失成本较高的显著预测因素。既往行脾切除术是生产力损失成本的负性显著预测因素。

结论

在阿联酋,TDT与大量生产力损失和间接成本相关。旨在有效控制输血依赖型地中海贫血的卫生政策是必要的,可为患者和雇主节省成本。

相似文献

1
Productivity Loss and Associated Costs Among Patients with Transfusion-Dependent Thalassemia in Dubai, United Arab Emirates.阿拉伯联合酋长国迪拜依赖输血的地中海贫血患者的生产力损失及相关成本
Clinicoecon Outcomes Res. 2021 Sep 29;13:853-862. doi: 10.2147/CEOR.S334724. eCollection 2021.
2
Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study.阿联酋迪拜依赖输血的地中海贫血症患者的医疗资源利用和直接成本:一项回顾性疾病成本研究。
BMC Health Serv Res. 2022 Mar 5;22(1):304. doi: 10.1186/s12913-022-07663-6.
3
The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.2018年加拿大炎症性肠病的影响:炎症性肠病护理的间接成本
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S34-S41. doi: 10.1093/jcag/gwy050. Epub 2018 Nov 2.
4
The economic burden of systemic lupus erythematosus in United Arab Emirates.阿联酋红斑狼疮的经济负担。
J Med Econ. 2024;27(sup1):35-45. doi: 10.1080/13696998.2024.2318996. Epub 2024 Mar 11.
5
The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.iMTA生产力成本问卷:一种用于测量和评估与健康相关的生产力损失的标准化工具。
Value Health. 2015 Sep;18(6):753-8. doi: 10.1016/j.jval.2015.05.009. Epub 2015 Aug 20.
6
Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.克罗恩病的健康相关生活质量损害及间接成本:波兰的一项自我报告研究
PLoS One. 2016 Dec 16;11(12):e0168586. doi: 10.1371/journal.pone.0168586. eCollection 2016.
7
Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study.在迪拜成人肺炎患者的实际疾病成本评估——一项索赔数据库研究。
PLoS One. 2021 Sep 1;16(9):e0256856. doi: 10.1371/journal.pone.0256856. eCollection 2021.
8
Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study.美国大型医疗保健系统员工出勤主义数据四年回顾:一项回顾性患病率研究。
Hum Resour Health. 2018 Nov 9;16(1):59. doi: 10.1186/s12960-018-0321-9.
9
Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective.从社会角度看马来西亚输血依赖型地中海贫血患者管理的经济负担。
Orphanet J Rare Dis. 2021 Apr 7;16(1):157. doi: 10.1186/s13023-021-01791-8.
10
Healthcare Resource Utilization and Direct Cost of Patients with Atopic Dermatitis in Dubai, United Arab Emirates: A Retrospective Cohort Study.阿拉伯联合酋长国迪拜特应性皮炎患者的医疗资源利用情况及直接成本:一项回顾性队列研究
Dermatol Ther (Heidelb). 2022 Jul 19:1-25. doi: 10.1007/s13555-022-00769-z.

引用本文的文献

1
Systematic literature review of the indirect costs and humanistic burden of β-thalassemia.β地中海贫血间接成本与人文负担的系统文献综述
Ther Adv Hematol. 2024 Sep 18;15:20406207241270872. doi: 10.1177/20406207241270872. eCollection 2024.
2
Systematic review and evidence gap assessment of the clinical, quality of life, and economic burden of alpha-thalassemia.α地中海贫血临床、生活质量及经济负担的系统评价与证据缺口评估
EJHaem. 2024 Apr 2;5(3):541-547. doi: 10.1002/jha2.882. eCollection 2024 Jun.
3
Combatting thalassemia in the United Arab Emirates.防治阿联酋的地中海贫血症。
Int Health. 2023 Nov 3;15(6):752-753. doi: 10.1093/inthealth/ihad011.

本文引用的文献

1
Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review.疾病经济负担研究中生产力成本的摩擦成本估算与人力资本估算的比较:综述。
Appl Health Econ Health Policy. 2018 Dec;16(6):765-778. doi: 10.1007/s40258-018-0416-4.
2
β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint.β地中海贫血在旧世界的分布:从历史角度看一种古老的疾病
Mediterr J Hematol Infect Dis. 2017 Feb 20;9(1):e2017018. doi: 10.4084/MJHID.2017.018. eCollection 2017.
3
Thalassemia in the United Arab Emirates: Why it can be prevented but not eradicated.阿拉伯联合酋长国的地中海贫血:为何它可预防却无法根除。
PLoS One. 2017 Jan 30;12(1):e0170485. doi: 10.1371/journal.pone.0170485. eCollection 2017.
4
Economic Burden of Thalassemia Major in Iran, 2015.2015年伊朗重型地中海贫血的经济负担
J Res Health Sci. 2016 Summer;16(3):111-115.
5
Splenectomy for people with thalassaemia major or intermedia.为重型或中间型地中海贫血患者进行脾切除术。
Cochrane Database Syst Rev. 2016 Jun 14(6):CD010517. doi: 10.1002/14651858.CD010517.pub2.
6
The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.iMTA生产力成本问卷:一种用于测量和评估与健康相关的生产力损失的标准化工具。
Value Health. 2015 Sep;18(6):753-8. doi: 10.1016/j.jval.2015.05.009. Epub 2015 Aug 20.
7
Hemoglobinopathy carrier prevalence in the United Arab Emirates: first analysis of the Dubai Health Authority premarital screening program results.阿拉伯联合酋长国血红蛋白病携带者患病率:迪拜卫生局婚前筛查项目结果的首次分析
Hemoglobin. 2013;37(4):359-68. doi: 10.3109/03630269.2013.791627. Epub 2013 May 7.
8
Expenditure to treat thalassaemia: an experience at a tertiary care hospital in India.地中海贫血治疗费用:印度一家三级护理医院的经验
Iran J Public Health. 2010;39(1):78-84. Epub 2010 Mar 31.
9
Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children.泰国儿童β地中海贫血/Hb E和重型β地中海贫血的经济负担。
BMC Res Notes. 2010 Jan 30;3:29. doi: 10.1186/1756-0500-3-29.
10
Global epidemiology of haemoglobin disorders and derived service indicators.血红蛋白疾病的全球流行病学及相关服务指标
Bull World Health Organ. 2008 Jun;86(6):480-7. doi: 10.2471/blt.06.036673.